Nasdaq biol.

Find the latest SEC Filings data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com. LAKE FOREST, Calif., Aug. 31, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced a strategic plan to partner with postgraduate dental specialty ...About · Highlight. A world's leading dental laser company. Industry · Exchange. NASDAQ · Listing Date. 11/12/1992 · Established Date · Full-time Employees.LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ...BIOLASE's CEO is John Beaver, appointed in Feb 2021, has a tenure of 2.75 years. total yearly compensation is $733.09K, comprised of 51.2% salary and 48.8% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth $152.65. The average tenure of the management team and the board of directors is 2 years ...

Nov 22, 2023 · BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ... BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary 2022 fourth quarter revenue is expected to be between ...

15 May 2021 ... BIOLASE (NASDAQ:BIOL) Share Prices Have Dropped 88% In The Last Five Years ... Some stocks are best avoided. We really hate to see fellow ...

FOOTHILL RANCH, Calif., March 23, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that President and CEO, John Beaver, has been invited to ...Feb 10, 2022 · The image below, which you can click on for greater detail, shows that BIOLASE had debt of US$13.5m at the end of September 2021, a reduction from US$16.1m over a year. But it also has US$33.4m in ... Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.An analysis of the stock market reaction to the announcements of the UK Soft Drinks Industry Levy. Econ Hum Biol. 2020 Aug:38:100834. doi: 10.1016/j.ehb ...LAKE FOREST, Calif., June 21, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, announced today the extension of its digital learning webinar series ...

FOOTHILL RANCH, Calif., May 16, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that it has received notice from the Nasdaq Stock Market LLC ...

BIOLASE, Inc. 17 Nov, 2021, 16:05 ET. FOOTHILL RANCH, Calif., Nov. 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote TODAY ...

An analysis of the stock market reaction to the announcements of the UK Soft Drinks Industry Levy. Econ Hum Biol. 2020 Aug:38:100834. doi: 10.1016/j.ehb ...Nov 18, 2023 · BIOLASE Stock Performance. Shares of BIOL stock opened at $1.25 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 1.40 and a debt-to-equity ratio of 34.06. The firm has a 50 day moving average price of $1.78 and a two-hundred day moving average price of $11.22. BIOLASE has a 12-month low of $1.07 and a 12-month high of $175.99. Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W...Nov 8, 2023 · Biolase Inc (NASDAQ:BIOL) trade information. Instantly BIOL has been showing a green trend so far today with a performance of 5.70% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.7500 on Tuesday, 11/07/23 increased the stock’s daily price by 4.57%. As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 75,000 units ...

Biolase Inc BIOL Morningstar Rating Stock XNAS Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance...LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 per pre ...Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. BIOL shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender.Jun 13, 2021 · Biolase Inc (NASDAQ:BIOL) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for BIOL is 19.8. Stocks with higher ... The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023.The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months ...

Investors in BIOLASE, Inc. (NASDAQ:BIOL) had a good week, as its shares rose 7.1% to close at US$0.29 following the release of its third-quarter results. It was a pretty bad result overall; while ...BIOL. The Nasdaq Stock Market LLC. (Nasdaq Capital Market). Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 ...

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update PR Newswire DALLAS, Oct. 18, 2023 DALLAS, Oct. 18, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ('SWK' or t...At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ...Biolase (NASDAQ:BIOL) has filed to offering 125,000 unites, each consisting of:One Share of Series J Convertible Preferred Stock with a Liquidation Preference of $100.00 and One Warrant to... Investing.com; Aug 30, 2023 21:35FOOTHILL RANCH, Calif., May 16, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that it has received notice from the Nasdaq Stock Market LLC ...BIOLASE, Inc. (NASDAQ:BIOL) fell 43.3% to $1.85 in pre-market trading after the company announced pricing of $4.5 million underwritten public offering of Series J convertible redeemable preferred ...Nov 22, 2023 · BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ... The stock was up 8.89% to $3.43 in after-hours trading. Agios Reports Positive Phase 3 Data For Mitapivat In Treating Genetic Blood Disorder. Agios Pharmaceuticals Inc (NASDAQ:AGIO) said that the ...LAKE FOREST, Calif. , Nov. 9, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial …

LAKE FOREST, Calif., Aug. 24, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced it has been invited to present at the Lake Street 6 th Annual ...

Biolase (NASDAQ: BIOL) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news for investors in BIOL stock is the company’s ...

Jan 10, 2023 · LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 per pre ... BIOLASE, Inc. (NASDAQ:BIOL) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ETCompany Participants. Todd Kehrli - Investor Relations, EVC Group. John Beaver - President and Chief Executive ...Predictive Oncology (NASDAQ: POAI) Biolase (NASDAQ: BIOL) CohBar (NASDAQ: CWBR) Vista Gold (NYSEAMERICAN: VGZ) Calyxt (NASDAQ: CLXT) Clearside Biomedical (NASDAQ: CLSD) Penny Stocks Under $3 ...FOOTHILL RANCH, Calif., Sept. 11, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and ...BIOL technical analysis. This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Biolase, Inc. is based on the most popular technical …LAKE FOREST, Calif., June 21, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, announced today the extension of its digital learning webinar series ...Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...BIOLASE (NASDAQ:BIOL) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment?We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.15 May 2021 ... BIOLASE (NASDAQ:BIOL) Share Prices Have Dropped 88% In The Last Five Years ... Some stocks are best avoided. We really hate to see fellow ...BIOL’s shares have dropped by -21.84% in the last five days, while they have subtracted -8.67% in the last month. Further, it is currently trading at a price-to-book ratio of 1.12. LORD JONATHAN T MD, Director, of BIOLASE Inc. (BIOL), sold 11,038 BIOLASE Inc. stock in an exchange on Dec 15.2 analysts have issued 1-year price objectives for BIOLASE's shares. Their BIOL share price targets range from $4.00 to $150.00. On average, they anticipate the company's stock price to reach $77.00 in the next year. This suggests a possible upside of 6,900.0% from the stock's current price.

Nov 24, 2021 · At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ... These institutions hold a total of 1 shares. Largest shareholders include Huntington National Bank . Biolase Inc (NASDAQ:BIOL) institutional ownership structure ...LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that its Board of Directors declared ...Instagram:https://instagram. most expensive quarter coinstart engine kevin o'learymcb bankcheap oil stocks under dollar5 Find the latest on short interest for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com. which broker is best for day tradinghow to buy shiba inu coin BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2023 financial and operating results on Thursday, August 10, 2023, after the ...BIOLASE's CEO is John Beaver, appointed in Feb 2021, has a tenure of 2.75 years. total yearly compensation is $733.09K, comprised of 51.2% salary and 48.8% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth $152.65. The average tenure of the management team and the board of directors is 2 years ... uvxy short interest NASDAQNYSEIBEX35LSEDAXCRYPTO. Buscar. NASDAQ:BIOL. BIOLASE Inc. Sector. Health. Industry. Medical supplies and equipment. 1,65 $ Last price. -0,03 $ VARIATION.Aug 10, 2023 · BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - EVC GroupJohn Beaver -... Nov 17, 2021 · BIOLASE, Inc. 17 Nov, 2021, 16:05 ET. FOOTHILL RANCH, Calif., Nov. 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote TODAY ...